Sign up for Table of Contents Alerts.
Email this page
Print this page
Perspectives
Prostaglandin E2: Making More of Your Marrow
Allegra M. Lord, Trista E. North and Leonard I. Zon
volume 6 | issue 24
15 December 2007Pages: 3054 - 3057
Subscribe to this journal for $129/year
We have recently demonstrated through a chemical screen in the zebrafish embryo that prostaglandin E2 (PGE2) is an evolutionarily conserved regulator of hematopoietic stem cell (HSC) number. These results have further been confirmed by in vitro and in vivo studies in the murine model. Bioactive PGE2 derivatives have potential clinical application to accelerate recovery of the hematopoietic system following chemotherapy or irradiation. Ex vivo expansion of HSCs prior to stem cell transplantation may improve reconstitution of hematopoiesis and immune function. This article aims to summarize current knowledge of PGE2-mediated regulation of blood cell homeostasis as well as to discuss the proposed use of PGE2 to expand hematopoietic stem cells for transplantation in the clinical setting.
Authors
Allegra M. Lord
Harvard Medical School; Boston, MA
Trista E. North
Harvard Medical School; Boston, MA
Leonard I. Zon
Harvard Medical School; Boston, MA




